Aeras

10/01/2018

"We believe that the time is now right to join the expertise within Aeras & to build on the recent findings & accelerate progress towards new more effective TB vaccines." Aeras CEO Jacqui Shea on transfer of clinical assets. Read more: https://bit.ly/2OYFoXm

Data from two phase II clinical trials conducted by Aeras and partners indicate promise for future of TB vaccine Development

10/01/2018

Pleased to announce that has acquired vaccine clinical programs & assets, so we can make a greater impact on the world’s two most urgent global health threats. Learn more: https://bit.ly/2OYFoXm

09/28/2018

ICYMI: Joint statement made at the by and Working Groups:

A statement from Aeras, FIND, TB Alliance, TBVI, and the Stop TB Partnership Working Groups.

09/26/2018

ICYMI: Groundbreaking Ph II study from Aeras and shows potential for TB vaccines: https://bit.ly/2QawgyV The field will not continue to make progress like this without investments in TB R&D

09/25/2018

Aeras CEO Jacqui Shea on the latest trial results: https://bit.ly/2MZEh7S

09/25/2018

Dr Emmanuel Hanon, Senior VP & Head of R&D, Global Vaccines on groundbreaking trial results: https://bit.ly/2MZEh7S

09/25/2018

"The results reinforce the importance of international collaborations, set the stage for testing additional candidates, & offer renewed hope that effective new vaccines can be developed for TB" - Dr. Barry Bloom, on breakthrough TB vaccine study in NEJM

Editorial from The New England Journal of Medicine — New Promise for Vaccines against Tuberculosis

09/25/2018

Grateful to trial participants, families, communities & partners who made this scientific breakthrough possible https://bit.ly/2QTW1ox Be Part Yoluntu Centre PHRU Setshaba Research Centre Zambart

09/25/2018

In a scientific breakthrough, TB vaccine M72/AS01E prevents active pulmonary tuberculosis in HIV negative adults in Phase II study: https://bit.ly/2QTW1ox

Original Article from The New England Journal of Medicine — Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis

09/24/2018

Wednesday is the High Level Meeting on TB and there's never been a more critical time for global leaders to step up. Demand action to accelerate the development of new tools and invest the funds necessary to !

09/24/2018

"If we had an effective vaccine we could transform the state of this epidemic, and together we could make TB history." - Aeras CEO Jacqui Shea at the Summit today. Let's make history at the this week with a monumental commitment to TB R&D!

09/24/2018

"If we had an effective we could transform the state of this epidemic, and together we could make history." Our CEO Jacqueline Shea at